Promises and Pitfalls of Calcineurin Inhibitors in COVID-19: A Systematic Review and Meta-analysis of Controlled Trials.

Behrooz HeydariAdeleh SahebnasaghMohammad Ali OmraniSaeed AzimiMohammad Hossein DehghaniAmin Salehi-AbargoueiFarnoosh FarmanFatemeh Saghafi

Published in: Current medicinal chemistry (2024)

CIs are able to inhibit the virus nucleocapsid protein so that they can prevent replication and respiratory tract tissue damage caused by SARS-CoV-2. Based on the characteristics mentioned in detail, CIs can play a potential therapeutic role for COVID-19 patients.

Keyphrases

sars cov
respiratory tract
respiratory syndrome coronavirus
oxidative stress
coronavirus disease
amino acid